Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy

Nanoscale ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 3317-3329 ◽  
Author(s):  
Wei Du ◽  
Chen Chen ◽  
Peng Sun ◽  
Shengchang Zhang ◽  
Jing Zhang ◽  
...  

Biomimetic drug-based nanohybrids boost immune checkpoint blockade-based cancer therapy through eliciting an immune hot tumor niche.

Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1655
Author(s):  
Cinzia Solinas ◽  
Debora Fumagalli ◽  
Maria Vittoria Dieci

The present commentary synthesizes the current evidence on the role of the immune response in HER2-positive breast cancer. It points out the strengths and weaknesses of the findings observed so far, particularly in the early setting, including the clinical significance of scoring tumor-infiltrating lymphocytes. A figure proposing research hypotheses for the implementation of immune checkpoint blockade use for patient candidates to neoadjuvant treatment is presented.


2016 ◽  
Vol 16 (5) ◽  
pp. 275-287 ◽  
Author(s):  
Suzanne L. Topalian ◽  
Janis M. Taube ◽  
Robert A. Anders ◽  
Drew M. Pardoll

Author(s):  
Simona Camorani ◽  
Margherita Passariello ◽  
Lisa Agnello ◽  
Silvia Esposito ◽  
Francesca Collina ◽  
...  

Theranostics ◽  
2019 ◽  
Vol 9 (19) ◽  
pp. 5542-5557 ◽  
Author(s):  
Zeqian Huang ◽  
Gaofei Wei ◽  
Zishan Zeng ◽  
Yanjuan Huang ◽  
Liangfeng Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document